Trialbee: advisory board
Patient matching platform provider Trialbee has announced its new advisory board, intended to provide insights and expertise from a broad range of experts from across the trial ecosystem. The board reportedly will work to drive the growth of the company’s solutions to increase trial enrollment performance.
“As much as things have changed since the pandemic, enrolling representative patient populations for a given trial on time remains the biggest challenge in bringing new drugs and vaccines to market,” said Trialbee CEO Matt Walz. “The collective experience we’ve harnessed with our advisory board better enables Trialbee to weigh innovative technologies and streamline the enrollment performance.”